Evidence for the formation of a novel cyclopentenone isoprostane, 15- A(2t)-isoprostane (8-iso-prostaglandin A2) in vivo

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1436, Issue 3, 1999, Pages 550-556

  Chen, Yan ^a   Zackert, William E ^a   Roberts II, L Jackson ^a   Morrow, Jason D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclopentenone; Eicosanoid; Isoprostane; Lipid peroxidation; Prostaglandin

Indexed keywords

8 ISOPROSTAGLANDIN A2; CARBON TETRACHLORIDE; CYCLOPENTANONE DERIVATIVE; ISOPROSTANE DERIVATIVE; LIVER EXTRACT; PROSTAGLANDIN A2; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN J2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEHYDRATION; EXTRACTION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LIPID PEROXIDATION; LIVER; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

ANIMALS; CARBON TETRACHLORIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LIVER; OXIDATIVE STRESS; PROSTAGLANDINS A; RATS; RATS, SPRAGUE-DAWLEY; TRITIUM;

EID: 0033521691     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(98)00168-4     Document Type: Article

References (20)

1. 2. Biochemistry. 29:1990;3760-3765.
2. Honn K.V., Marnett L.J. Requirement of a reactive alpha, beta unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by 'A' series prostaglandin. Biochem. Biophys. Res. Commun. 129:1985;34-40.
3. Boyland E., Chasseaud L.F. Enzyme catalysing conjugations of glutathione with α,β-unsaturated carbonyl compounds. Biochem. J. 109:1968;651-661.
4. 2 in nuclei. J. Pharmacol. Exp. Ther. 242:1987;306-311.
5. 2 and related compounds: an update. Prostaglandins Leukot. Essent. Fatty Acids. 47:1992;1-12.
6. Polet H., Levine L. Metabolism of prostaglandin E, A, and C in serum. J. Biol. Chem. 250:1975;351-357.
7. R.J. Kulmacz, Biosynthesis of prostaglandin, in: A.L. Willis (Ed.), Handbook of Eicosanoids: Prostaglandins and Related Lipids, vol. 1, Chemical and Biochemical Aspects, CRC Press, Boca Raton, FL, 1987, pp. 163-174.
8. Jansson H.T. Jr., Powers R.E. Endogenous prostaglandin A's (PGAs):fact or artifact in biological systems. Prog. Lipid Res. 20:1981;787-790.
9. 2 in human urine. J. Biol. Chem. 263:1988;16619-16635.
10. 2-like compounds are produced in vivo in human by a non-cyclooxygenase free radical catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 87:1990;9383-9387.
11. Roberts L.J. II, Morrow J.D. The generation and actions of isoprostanes. Biochim. Biophys. Acta. 1345:1997;121-135.
12. 2), is formed in vivo. J. Lipid Res. 39:1998;1589-1593.
13. J.D. Morrow, Y. Chen, W.E. Zackert, L.J. Roberts, The isoprostanes: recent advance, in: L. Packer, A.S.H. Ong (Eds.), Biological Oxidants and Antioxidants: Molecular Mechanisms and Health Effects, AOCS Press, Champaign, IL, 1998, pp 72-78.
14. T. Liu, A. Stern, L.J. Roberts, J.D. Morrow, The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. J. Biomed. Sci., in press.
15. 2. Identification of products formed in vitro. J. Biol. Chem. 258:1983;11713-11718.
16. 2) under strongly acidic and basic conditions. J. Pharm. Sci. 66:1977;1590-1595.
17. Honn K.V., Weller P., Marnett L.J. Effects of prostaglandins possessing an alpha, beta-unsaturated carbonyl on tumor growth and differentiation. Adv. Prostaglandin Thromboxane Leukot. Res. 15:1985;411-413.
18. 2 with intracellular glutathione and enhancement of its antiproliferation activity by glutathione depletion. Cancer Res. 50:1990;1879-1885.
19. 2 in vitro and in vivo. Cancer Res. 46:1986;3538-3542.
20. Bregman M.D., Funk C., Fukushima M. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. Cancer Res. 46:1986;2740-2744.